| N5 |
Discovery and evaluation of alternative targets and
technologies for the serodiagnosis of pertussis in vaccinated children,
adolescents and adults |
CDC - NCID |
Sanden, Gary |
| N8 |
Safety and Immunogenicity of Repeat Revaccination with
Pneumococcal Polysaccharide Vaccine |
CDC - NCID |
Hammitt, Laura
|
| N9 |
Determinants of cytomegalovirus (CMV) reactivation,
reinfection, and the host immune response |
CDC - NCID |
Cannon, Michael |
| N10 |
Generation of reassortant vaccine seed viruses against
H7 subtype of avian influenza viruses |
CDC - NCID |
Matsuoka, Yumiko
|
| N11 |
Assessing accuracy of parental report vaccination of
Hepatitis A vaccination of children and correlation with Hepatitis
B and varicella vaccine coverage |
CDC - NCID |
Fiore, Anthony |
| N14 |
Developing and implementing an educational campaign
on meningococcal disease and vaccination - a stakeholders' meeting
|
CDC - NCID |
Rosenstein,
Nancy |
| N18 |
Immunogenic and protective Pandemic influenza vaccines
for the elderly; Preclinical studies in aged mouse model |
CDC - NCID |
Katz, Jacqueline
|
| N19 |
Long term impact of Conjugate Pneumococcal Vaccine (PCV)
on pneumococcal nasopharyngeal colonization |
CDC - NCID |
Whitney, Cynthia
|
| N20 |
Evaluation of functional antibodies elicited to PsaA
and its relevant epitopes as a consequence of pneumococcal colonization
and/or acute otitis media infection |
CDC - NCID |
Steiner, Sandra
|
| N21 |
Invasive pneumococcal disease in the conjugate vaccine
era: Characterization of remaining cases and planning for
future vaccines |
CDC - NCID |
Beall, Bernard |
| N28 |
Studies towards developing SARS-CoV-sepecific diagnostics
and antibody-based potency assay for candidate vaccines |
CBER |
Atreya, C.D. |
| N31 |
Vaccine virus neurovirulence: Dissecting the genetic
determinants of mumps virus neurovirulence |
CBER |
Carbone, Kathryn
|
| N33 |
Development of microarray-based quality control test
for cell line identity and Mycoplasma contamination |
CBER |
Chizhikov, Vladimir
|
| N38 |
Development of endogenous retrovirus detection assays for cell
substrate evaluation and vaccine safety |
CBER |
Khan, Arifa |
| N40 |
DNA Vaccines: Influence of Novel Immunization
Strategies on the Frequency of Plasmid Integration |
CBER |
Kinman, Dennis
|
| N41 |
Development of an Assay that can be standardized and validated
to assess the risk of Oncogenic Activity of residual Cell-Substrate
DNA in Viral Vaccines |
CBER |
Lewis, Andrew |
| N44 |
Development of candidate live attenuated West Nile vaccine
viruses by site-directed mutagenesis of a West Nile infectious DNA
|
CBER |
Markoff, Lewis |
| N47 |
Evaluating the safety of new tuberculosis vaccines: Development
of an assay to measure Koch reactions in animals infected with Mycobacterium
tuberculosis |
CBER |
Morris, Sheldon |
| N49 |
Targeted Design of Polysaccharide Toxoid Conjugate Vaccines
|
CBER |
Vann, Willie |
| N50 |
Workshop on Acceleration of Vaccines Against Enteric Diseases
for Pediatric Use |
NIH |
Van De Verg,
Lillian |
| N51 |
Carbohydrate Moieties as Vaccine Candidates |
NIH |
Taylor, Christopher
|
| N54 |
cGMP Production of a Pilot Lot of Typhoid Fever Vaccine Ty800
|
NIH |
Schmitt, Clare |
| N58 |
Surveillance for Adverse Events Following Measles Vaccination
in HIV-Infected Children After a Mass Vaccination Campaign |
CDC NIP |
Perry, Robert |
| N60 |
Diagnosis of Measles by Using Filter Paper Blood Spots Specimens
|
CDC NIP |
Uzicanin, Amra |
| N61 |
Assessment of Influenza Vaccine Effectiveness and Impact among
Young Children in Three Communities |
CDC NIP |
Iwane, Marika |
| N62 |
Why parents claim immunization exemptions and development and
evaluation of potential interventions |
CDC NIP |
Gust, Deborah |
| N65 |
A comparison of the cost-effectiveness of using measles versus
measles-rubella vaccine for a national vaccination campaign in Sri
Lanka |
CDC NIP |
Cairns, Lisa |
| N67 |
Influenza vaccination coverage and reasons for vaccination/non-vaccination
among adults aged 50-64 years |
CDC NIP |
Santibanez, Tammy
|
| N68 |
Nursing attitudes and practices around adult vaccination |
CDC NIP |
Wortley, Pascale |
| N70 |
Validation of the novel CDC pertussis PCR assay and the novel
FDA pertussis serologic assays to allow faster and more accurate
diagnosis of pertussis |
CDC NIP |
Cortese, Margaret |
| N73 |
Analysis of global polio vaccine supply and stockpile issues
|
CDC NIP |
Watkins, Margaret |
| N77 |
Multinational Consultation in Support of the Development of
a national Pertussis Control Plan for the United States |
CDC NIP |
Murphy, Trudy |
| N81 |
Surveillance for rotavirus and intussusception: a component
of a phase III evaluation of RIX 4414 rotavirus vaccine in Bangladesh
|
USAID |
Breiman, Robert |
| N82 |
Surveillance for pneumonia, meningitis and mortality in Bangladesh:
Preparing for demonstration of impact of introduction of a package
of effective respiratory vaccines |
USAID |
Breiman, Robert |
| N86 |
Correlation of the titer of vaccine virus shedding with adverse
events after trivalent, cold-adapted influenza vaccine administration
in children |
CBER |
Izurieta, Hector |
| N87 |
Production of sheep antisera against H5 |
CBER |
Levandowski, Roland |
